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1  | INTRODUC TION
The oral cavity, including the lip, is the sixth most common cancer 
in the world.1 Oral squamous cell carcinoma (OSCC) accounts for 
more than 90% of all oral cancer.2 OSCC is associated with a poor 
5-year survival rate of <50%, and this is due to the spread of OSCC 
to regional and distant sites.3 One of the significant features of can-
cer cells facilitating spread is their ability to detach from the epithe-
lium, break through the basement membrane and access lymphatic, 
vascular and nerve tissues.4 Perineural invasion (PNI), also called 
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Abstract
Background: The objective of this study was to characterise the incidence and prog-
nostic correlation of perineural invasion (PNI) in oral squamous cell carcinoma and 
determine whether nerve growth factor and its receptor tyrosine Kinase A expres-
sion could be used as biological markers for PNI.
Methods: A retrospective review of pathology reports of 430 patients with oral 
squamous cell carcinoma who were treated from 1992 to 2014 in Tayside, Scotland, 
was carried out. The expression of nerve growth factor and tyrosine kinase A was 
assessed with immunohistochemistry in 132 tissue sections of oral squamous cell 
carcinoma.
Results: Perineural invasion was identified in 17.4% of oral squamous cell carcino-
mas. High expression of nerve growth factor and tyrosine kinase A was seen in 84% 
and 92% of oral squamous cell carcinoma, respectively. Tumours with PNI expressed 
nerve growth factor and tyrosine kinase A with a greater frequency than tumours 
without PNI. PNI and high expression of nerve growth factor were significantly as-
sociated with pain. PNI was significantly associated with stage IV tumours and poor 
disease-specific survival.
Conclusions: A higher level of expression of nerve growth factor and tyrosine kinase 
A may predict PNI and therefore may be considered as biological markers for PNI 
in oral squamous cell carcinoma. PNI and nerve growth factor overexpression may 
contribute to the pain generation in oral cancer patients. PNI and nerve growth fac-
tor expression can predict the aggressiveness and prognosis of oral squamous cell 
carcinoma patients.
K E Y W O R D S
nerve growth factor, oral squamous cell carcinoma, perineural invasion, tyrosine kinase A
2  |     ALKHADAR et AL.
perineural spread and neurotropism, is used to describe the process 
of cancer cells “invasion in, around and through the nerves”.5 PNI 
in cancer is also defined as “tumour in close proximity to nerve and 
involving at least 33% of its circumference or tumour cells within 
any of the 3 layers of the nerve sheath”.4 There is considerable vari-
ability in the reported incidence rates of PNI in OSCC worldwide. 
At sites such as the tongue and/or floor of the mouth, PNI was de-
tected in up to 70% of OSCC, whereas cancer of the lower lip has a 
lower rate of PNI at 5.2%.6 PNI exhibited by some OSCC has been 
known as an independent predictor of poor prognosis and an indi-
cator of aggressive behaviour.7-9 The presence of PNI is significantly 
correlated with advanced T and N tumour staging, extranodal ex-
tension, poor tumour differentiation, lymphovascular invasion and 
increased depth of invasion, and therefore, PNI seems to be critical 
to prognosis in OSCC.10,11 PNI is known to be implicated in pain gen-
eration in patients with adenoid cystic carcinoma, pancreatic can-
cer and OSCC.12-14 A number of neurotrophic factors such as nerve 
growth factor (NGF) and its high affinity tyrosine kinase A (TrkA) 
receptor are likely to be involved in the possible molecular mecha-
nism of PNI.15 Few reports have revealed the association between 
the NGF and/or TrkA with PNI in OSCC.16-20 Given the paucity of 
information on the role of these factors in PNI and their possible 
role in the development of pain in OSCC, this study was undertaken 
to characterise the incidence and prognostic correlation of PNI in 
OSCC and to determine whether NGF and its receptor TrkA expres-
sions could be used as potential markers for PNI in ex-vivo OSCC.
2  | MATERIAL S AND METHODS
2.1 | Patients and tissue collections
A retrospective review was undertaken of the histopathology re-
ports of 430 patients with OSCC from 1992 to 2014 in Tayside, 
Scotland, who were reviewed or a minimum of 5 years or until death. 
The study was approved by the NHS Tayside, Scotland (Caldicott/
CSAppHA1350), and Tayside Medical Science Centre Research and 
Development (14/ES/0015(HIC). Subjects were excluded if they 
were under 18 years of age, had histological findings other than pri-
mary OSCC or any patients diagnosed with oropharyngeal SCC.
Archival OSCC specimens were selected from 430 patients diag-
nosed with primary OSCC for immunohistochemical (IHC) analysis. 
Tumours with evidence of PNI histopathologically were selected as 
the study group whilst the control group comprised patients with 
no histopathological evidence of PNI. Both groups were matched 
for the following factors: age, gender and tumour site. Those who 
had received pre-operative radiotherapy or chemotherapy were 
excluded. In order to ensure an equivalent number of specimens in 
each group, a systematic sampling method was used to randomly 
select the samples for the control group.21 In total, 132 of forma-
lin-fixed paraffin-embedded (FFPE) tissue blocks comprising 61 PNI-
positive and 71 PNI-negative OSCC were requested from Tayside 
Tissue Bank following approval (TR000388).
Baseline data were obtained from patient's medical records such 
as age, gender, smoking and alcohol history, clinical presentation, 
treatment modalities and survival status. Histopathological diag-
nostic findings (degree of differentiation, invasive front, tumour size 
(pT), nodal status (pN), depth of invasion (DOI) of 4 mm or above, 
lymphovascular invasion, PNI and bone invasion) had been reported 
according to the Royal College of Pathologists, dataset for histopa-
thology reporting of mucosal malignancies of the oral cavity.22 TNM 
staging was determined in accordance with the UICC, 7th edition.23
2.2 | Immunohistochemistry
The FFPE tissue blocks were sectioned at 5 µm, deparaffinised in xy-
lene and then rehydrated in serial ethanol solutions, before washing 
in distilled water for 5 minutes. Haematoxylin and eosin (H&E) stain-
ing of all sections was performed, and the sections were examined 
for evidence of PNI in OSCC sections (Figure 1). Then, 132 OSCC 
samples were probed with NGF (#365944) and TrkA (#7268) mouse 
monoclonal antibodies according to the manufacturer's instruc-
tion (Santa Cruz biotechnology, Inc). After deparaffinisation and 
F I G U R E  1   Haematoxylin and eosin stained sections of of PNI in OSCC. Complete encirclement of cancer cells around the nerve (A) (x100 
magnification). Incomplete encirclement of cancer cells around the nerves (B) (x100 magnification). Intraneural invasion of cancer cells within 
and around the nerve (C) (x200 magnification). N indicates the nerve, black arrows point to cancer cells around the nerve, red arrow point to 
tumour inside the nerve
(A) (B) (C)
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rehydration process, antigens were unmasked by heating the sec-
tions in 10mM sodium citrate buffer at 95ºC (pH 6.0) using a water 
bath, and sections were allowed to cool in the buffer for 20 minutes 
before washing in deionised H2O. The sections were incubated in 
1% H2O2 for 5 minutes to bock endogenous peroxidase activity, fol-
lowed by washing twice in PBS. Sections were blocked with 5% nor-
mal goat serum (NGS) in PBS for 1 hour at room temperature. This 
was followed by incubation with primary antibodies against NGF 
(1:50) and TrkA (1:50) diluted in 5% NGS/PBS in a humidified cham-
ber overnight at 4ºC. After equilibration, the sections were washed 
three times with PBS to remove the unbound antibody followed by 
incubation with biotinylated secondary antibody 1µg/ml diluted in 
5% NGS/PBS for 45 minutes in a humidified chamber, the sections 
were incubated for 30 minutes with the ABC reagent and the ex-
cess ABC reagent was removed from the slides by washing with PBS. 
Visualisation was achieved by incubation in peroxidase substrate 
and chromogen mixture (3, 3′-diaminobenzidine (DAB) and hydrogen 
peroxide prepared in house for 5 minutes. The sections were coun-
terstained with Mayer's haematoxylin (Sigma). The dehydration and 
mounting processes were followed as per manufactures instructions 
(Santa Cruz biotechnology). Positive controls used for NGF and TrkA 
were ductal epithelial cells in salivary gland tissues.16 The NGF and 
TrkA antibodies were blocked using the respective blocking peptide 
(#365944P and #7268P, respectively, Santa Cruz biotechnology) by 
adding twice the volume of peptide as the volume of antibody used. 
These tissues were used as negative control.
2.3 | Immunohistochemical score
Assessment of the staining was carried out according to the scor-
ing system reported previously in the literature with some modifica-
tion.16 Stained sections were scanned using a light microscope at low 
power. Tumour cells exhibiting a brown cytoplasmic, nuclear and/or 
surface membrane staining were counted as positive.
Analyses of intra-class correlation by the main observer twice and 
inter-class correlation by three independent observers were carried 
out to test the scoring results consistency gave a Cronbach's alpha 
of more than 0.8. NGF and TrkA staining scoring was performed as 
follows: the percentage of tissue staining was designated as 1 when 
0%-25% of tumour cells were stained, 2 when 25%-50% of tumour 
cells were stained and 3 when >50% of tumour cells were stained. 
The intensity of tissue staining was categorised as 1 for weak stain-
ing, 2 for moderate staining and 3 for strong staining. The final scor-
ing was determined according to the product of staining intensity 
and the percentage of tissue staining ranging from 0-6 categorised 
as low expression (IHC = 0-2) and high expression (IHC = 3-6).
2.4 | Statistical analysis
Data were analysed using SPSS package (IBM statistics version 22). 
Data related to categorical variables were described in terms of 
numbers with percentage and as mean with standard deviation (±) 
for continuous variables. Descriptive statistics were computed for 
each variable according to PNI status with a 95% confidence inter-
val. The correlation between PNI and NGF/TrkA expression status 
with clinical/histopathological characteristics was analysed by chi-
square or Fisher's exact test where appropriate. Spearman's correla-
tion (rs) was used to assess the significance of relationships between 
the expression level of NGF and TrkA. Five-year overall survival (OS), 
disease-specific survival (DSS) and disease-free survival (DFS)24 
were calculated using the Kaplan-Meier method, the difference in 
survival rate was assessed by log-rank test and a P-value of <.05 was 
considered statistically significant.
3  | RESULTS
3.1 | Analysis of the clinical data
A total of 430 OSCC patients' clinical data were analysed in this 
study, 242 (56%) were male and 188 (44%) female with an age range 
of 29 to 105 years (mean age 72.5 ± 12.2). The commonest site for 
OSCC was the tongue and floor of mouth for both PNI-positive 
(69.9%) and PNI-negative OSCC (68%). For those cases where data 
were available, more than 50% of the patient population were smok-
ers and 82% had a history of alcohol consumption. The demographi-
cal and clinical characteristics of 430 OSCC patients according to the 
presence and absence of PNI are summarised in Table 1.
3.2 | Correlation between PNI and 
clinicopathological parameters in OSCC cohort
PNI was seen in 75/430 (17.4%) of patients with OSCC. Thirty-five 
(46%) patients presented with a history of pain at the time of diag-
nosis in the PNI-positive group compared to 43 (12%) patients with 
PNI-negative group (P < .05). In the PNI-positive group, a significant 
proportion of patients (24%) had an advanced pathological T stage 
(T4), nodal involvement (N2) (21%), extranodal extension (26%), in-
creased DOI (>4 mm) (61%), discohesive invasive front (50%), poor 
tumour differentiation (38%) and lymphovascular invasion (34%), 
when compared to patients without PNI, and these results are highly 
significant, with P < .05. A third of the patients with PNI had stage 
IV disease (33%) (UICC staging) in comparison with patients without 
PNI the majority of whom presented with stage I (27%) (P < .05). It 
is important to note here that histopathological parameters of TNM 
stage, invasive front, grade of differentiation and DOI had a signifi-
cant proportion of missing data.
At the time of the analysis, 56 (74%) of 75 patients with PNI were 
deceased in comparison with 247 (69%) of 355 patients without PNI. 
Out of these 56 patients with PNI, 19 (34%) patients were reported 
dead due to OSCC. Descriptive statistics of the clinicopathological 
characteristics of 430 OSCC patients according to the presence and 
absence of PNI are shown in Table 2.
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3.3 | NGF and TrkA expression in OSCC samples
High expression of NGF was seen in 111 of 132 (84%) OSCC as an 
intense staining in the cytoplasm and nucleus of cancer cells in a 
diffuse pattern. One hundred and twenty-two (92%) OSCC had a 
high expression of TrkA that was present diffusely in the surface 
membrane and cytoplasm of tumour cells. Immunoreactivity of 
NGF and TrkA was weakly present in 21% and 8% of the OSCC, 
respectively (Figure 2). Neural tissues showed moderate to strong 
intensity of NGF and Trk immunoreactivity. A strong positive 
correlation was seen between NGF immunoreactivity and TrkA 
immunoreactivity in OSCC samples (rs = 0.65). rs = Spearman's 
correlation coefficient.
3.4 | Relationship between NGF and TrkA 
expression with clinicopathological parameters in 
OSCC samples
PNI-positive OSCC expressed NGF and TrkA with a greater fre-
quency than PNI-negative OSCC (P < .5). There were significant 
differences between NGF/TrkA expression levels, DOI > 4 mm and 
lymphovascular invasion (P < .05). Furthermore, patients who pre-
sented with pain had a significantly higher NGF expression in their 
tumour compared with patients with low NGF expression who pre-
sented with pain (P < .5). Correlation between NGF and TrkA expres-
sion levels and clinicopathological parameters including the presence 
and absence of PNI of 132 OSCC samples is shown in Table 3.
3.5 | Survival analysis
The presence of PNI was associated with poor DSS in OSCC (P < .05). 
The trend for OS and DFS was similar but not significant. The over-
all 5-year survival rate was worse for patients with OSCC with high 
expression of NGF and TrkA compared to OSCC patients with low 
NGF and TrkA expression (34% vs 48%, 34% vs 60%, respectively). 
However, Kaplan-Meier survival analysis revealed no significant as-
sociation of NGF and TrkA expression levels with OS, DSS and DFS 
(P > .05) (Figure 3).
4  | DISCUSSION
PNI is observed when cancer cells invade and grow along nerve 
tracts away from the primary tumour and is recognised as one of 
the most important prognostic factors in OSCC.9 Our study found 
that the incidence of PNI was 17.4% in OSCC, and this is consistent 
with the trend of overall frequency of PNI that ranges from 2.5% 
to 71% in OSCC.6 The vast majority of PNI-positive OSCC were tu-
mours arising in the tongue and floor of the mouth. These results 
are consistent with other studies where heterogeneous anatomical 
sites were employed.6 Some studies have shown that infiltration of 
the perineural space of the nerves by tumour cells correlates with 
tumour size, depth and pattern of invasion, the degree of tumour dif-
ferentiation, presence of nodal metastasis and presence of extran-
odal extension in OSCC.10,11,25 Our study demonstrates a significant 
correlation between the presence of PNI and these histological fea-
tures in OSCC.
The process of PNI requires activation of some neurotrophic 
growth factors such as NGF and its TrkA receptor that may play 
a role in the mechanism of PNI.26 Previous studies have shown a 
significant association of NGF and TrkA overexpression with PNI in 
TA B L E  1   Demographical and clinical characteristics of OSCC 
cohort according to the presence and absence of PNI
Variables
Patients without 
PNI, n = 355 
(82.6%)
Patients with 
PNI, n = 75 
(17.4%)
Gender
Male 202 (65.9) 40 (53.3)
Female 153 (43.1) 35 (46.7)
Age (y)
Mean ± (Range) 73.3 ± 12.1 
(34-105)
68.8 ± 12 
(29-95)
Smoking
Yes 105 (29.6) 23 (30.7)
No 36 (10.1) 15 (20)
Ex-smoker 31 (8.7) 8 (10.7)
Data missing 183 (51.5) 29 (38.7)
Alcohol
Yes 97 (27.3) 32 (42.7)
No 21 (5.9) 6 (8)
Data missing 237 (66.8) 37 (49.3)
Site
Tongue 133 (37.5) 35 (46.7)
Floor of the mouth 79 (22.4) 16 (21.3)
Tongue & floor of the 
mouth
12 (3.4) 5 (6.7)
Retromolar trigone 21 (5.9) 5 (6.7)
Alveolus 24 (6.8) 5 (6.7)
Buccal mucosa 41 (11.6) 3 (4)
Lower lip 40 (11.3) 3 (4)
Hard palate 5 (1.4) 3 (4)
Treatment
Surgery 220 (62) 57 (76)
Surgery + radiotherapy 
with/without 
chemotherapy
15 (4.2) 7 (9.3)
No surgery 
(Chemoradiotherapy)
120 (33.8) 11 (14.7)
Note: ± standard deviation.
Abbreviation: OSCC, oral squamous cell carcinoma; PNI, perineural 
invasion.
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OSCC.16-20 In the present study, we demonstrated NGF and TrkA 
expression in OSCC; interestingly, the expression levels were sig-
nificantly higher in PNI-positive compared with PNI-negative OSCC. 
Moreover, there was a positive relationship between the expres-
sion of NGF and TrkA in OSCC in agreement with another study 
on OSCC.16 Besides the cancer cells, immunoreactivity of NGF and 
TrkA was remarkably present in nerve tissues in OSCC in this study. 
Therefore, this may suggest that there is a close interaction between 
the cancer cells and neural tissue, where NGF is expressed by cancer 
cells causing tumour cells and nerves to grow together and enhance 
their physical contact, and therefore induce PNI. This hypothesis is 
supported by a previous study showed the influence of NGF/TrkA 
interactions between cancer cells and neural tissues in OSCC that 
may facilitate the development of PNI.16
The clinical features of PNI have been studied in different 
types of cancer, and it is well known that PNI is often clinically 
silent.27 However, in this study, PNI is notably accompanied by 
pain in OSCC patients with PNI. Another study also reported that 
pain was a symptom in the majority of patients with PNI-positive 
OSCC at the time of presentation.28 NGF and its receptor TrkA are 
believed to be major mediators of pain in pancreatic and prostate 
cancer.13,29 To our knowledge, this is the first report to show that 
overexpression of NGF might influence pain generation in patients 
with OSCC.
A previous study has shown an association of NGF overexpres-
sion with some pathological parameters in OSCC; however, TrkA im-
munoreactivity was not associated with any pathological factors in 
the same study.19 Interestingly, our findings demonstrated a signif-
icant correlation of NGF and TrkA overexpression with lymphovas-
cular invasion and increased DOI (>4mm) OSCC which might indicate 
that NGF and its receptor TrkA can predict aggressive behaviour of 
OSCC. This may contribute to the theory that NGF/TrkA may induce 
lymphovascularisation around nerves in cancers with an increase 
TA B L E  2   Descriptive statistics of the clinicopathological factors 
in the OSCC cohort according to the presence or absence of PNI
Variables
Patients 
without PNI, 
n = 355 (82.6%)
Patients 
with PNI, 
n = 75 
(17.4%) P-value
p-T Stage
T1 109 (30.7) 21 (28) .001*
T2 72 (20.3) 23 (30.7)
T3 19 (5.4) 1 (1.3)
T4 26 (7.3) 18 (24)
Data missing 129 (36.3) 12 (16)
p-N Stage
N0 181 (51) 38 (50.7) .004*
N1 14 (3.9) 9 (12)
N2 30 (8.5) 16 (21.30
N3 0 0
Data missing 130 (36.6) 12 (16)
p-Extracapsular Extension
Yes 33 (9.3) 20 (26.7) .0001*
No 322 (90.7) 55 (73.3)
p-DOI (mm)
<4 mm 89 (25.1) 10 (13.3) .0001*
>4 mm 112 (31.5) 46 (61.3)
Data missing 154 (43.3) 19 (25.3)
p-Histological grade
Well 57 (16.1) 3 (4) .001*
Moderate 207 (58.3) 38 (50.7)
Poor 82 (23.1) 29 (38.7)
Data missing 9 (2.5) 5 (6.7)
p-Invasive front
Cohesive 101 (28.5) 18 (24) .002*
Discohesive 78 (22) 38 (50.7)
Data missing 17 (49.6) 19 (25.3)
p-Lymphovascular Invasion
Yes 34 (9.6) 26 (34.7) .0001*
No 32 (90.4) 49 (65.3)
p-Bone invasion
Yes 22 (6.2) 8 (10.7) .1
No 333 (93.8) 67 (89.3) NS
TNM Staging
I 99 (27.9) 16 (21.3) .001*
II 50 (14.1) 18 (24)
III 32 (9) 4 (5.3)
IV 44 (12.4) 25 (33.3)
Data missing 130 (36.6) 12 (16)
Pain
Yes 43 (12.1) 35 (46.7) .0001*
(Continues)
Variables
Patients 
without PNI, 
n = 355 (82.6%)
Patients 
with PNI, 
n = 75 
(17.4%) P-value
No 312 (87.9) 40 (53.3)
Local recurrence
Yes 86 (24.2) 16 (21.3) .5
No 269 (75.8) 59 (78.7) NS
Survival status
Alive 108 (30.4) 19 (25.3) .2
Deceased 247 (69.6) 56 (74.7) NS
Deceased form 
OSCC
38 (15) 19 (34)
Note: Comparison between two groups by Pearson's chi-square or 
Fisher's exact test, where appropriate.
Abbreviations: NS, not significant; OSCC, oral squamous cell carcinoma; 
PNI, perineural invasion.
*Significant value. 
TA B L E  2   (Continued)
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DOI, thus supplying the nutrients for tumour and nerve growth 
which may enhance PNI.30
Some studies found a significant relationship between PNI and 
5-year survival rate in OSCC.7-9 In the current study, PNI was signifi-
cantly associated with a poorer 5-year DSS in OSCC patients. Few 
studies have evaluated the impact of NGF expression on patient's 
survival in OSCC, with conflicting reports of higher NGF expression 
being associated with a significantly worse overall survival19 and no 
association between NGF expression and survival.18 Our study found 
no significant association of NGF and TrkA expression levels with OS, 
DSS and DFS in OSCC. The variation in the prognostic significance of 
NGF and TrkA expression in OSCC in the literature and our study could 
have been due to the unequal distribution of parameters between the 
PNI-positive and PNI-negative group that might reduce the predictive 
power of NGF and TrkA as biomarkers, and the retrospective nature 
of this study that needs to be further validated in prospective studies. 
However, one of the strengths of this study is that it includes a large, 
well-characterised cohort of 430 cases of OSCC from a geographically 
defined population diagnosed and treated in NHS Tayside reporting 
the incidence and prognostic impact of PNI as a pathologic entity on 
patients with OSCC in Scotland. It also highlights the potential of NGF 
and TrkA as biomarkers of PNI-related OSCC. Further understanding 
F I G U R E  2   OSCC tissues stained 
with NGF and TrkA antibodies. 
Representative of high expression of 
NGF (A) and TrkA (B) in PNI-positive 
OSCC exhibiting intensive cytoplasmic/ 
nuclear NGF and cytoplasmic/membrane 
TrkA immunoreactivity in cancer cells 
invading the nerve. Representative of low 
expression of NGF (C) and TrkA (D) in PNI-
positive OSCC showing weak cytoplasmic/
nuclear NGF and cytoplasmic/membrane 
TrkA staining in cancer cells invading the 
nerve. Ductal epithelial cells in salivary 
gland tissues act as a strong positive 
control for NGF (E) and TrkA (F). Complete 
blocking of NGF and TrkA antibodies 
after incubation with blocking peptides 
and no immunoreactivity for NGF (G) and 
Trk (H) was detected in stained sections. 
N indicates the nerve, black arrows point 
to cancer cells, and a red arrow points 
to ductal epithelial cells in salivary gland 
tissue. Images were captured at x100 
magnification
(A) (B)
(C) (D)
(E) (F)
(G) (H)
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TA B L E  3   Correlation between NGF and TrkA expression level and clinicopathological parameters in OSCC samples
OSCC samples
NGF Expression
P-value
TrkA expression
P-
valueHigh n = 111 (84%) Low n = 21 (16%) High n = 122 (92%) Low n = 10 (8%)
p-T stage
T1 41 (39) 12 (57) 47 (40) 6 (60)
T2 34 (32) 7 (33) .2 37 (31) 4 (40) .2
T3 2 (2) 0 NS 2 (2) 0 NS
T4 29 (27) 2 (10) 31 (26) 0
Missing data 5 0 5 0
p-N Stage
N0 68 (64) 17 (81) .3 76 (65) 9 (90) .4
N1 16 (15) 1 (5) NS 17 (15) 0 NS
N2 22 (21) 3 (14) 24 (20) 1 (10)
N3 0 0 0 0
Data missing 5 0 5 0
p-Extracapsular Extension
Yes 31 (28) 4 (19) .3 34 (28) 1 (10) .2
No 80 (72) 17 (81) NS 88 (72) 9 (90) NS
p-DOI (mm)
<4 mm 21 (21) 11 (52) .003* 25 (23) 7 (70) .003*
>4 mm 79 (79) 10 (48) 86 (77) 3 (30)
Data missing 11 0 11 0
p-Histological grade
Well 11 (10) 1 (5) .3 11 (9) 1 (10) .7
Moderate 53 (48) 14 (66) NS 61 (50) 6 (60) NS
Poor 47 (42) 6 (28) 50 (41) 3 (30)
p-Invasive front
Cohesive 39 (39) 12 (57) .1 47 (43) 4 (40) .8
Discohesive 60 (61) 9 (43) NS 63 (57) 6 (60) NS
Data missing 12 0 12 0
Perineural Invasion
Yes 61 (55) 0 .0001* 61 (50) 0 .002*
No 50 (45) 21 (100) 61 (50) 10 (100)
p-Lymphovascular Invasion
Yes 35 (32) 1 (5) .01* 36 (30) 0 .04*
No 76 (68) 20 (95) 86 (70) 10 (100)
p-Bone invasion
Yes 14 (13) 2 (10) .6 16 (13) 0 .6
No 97 (87) 10 (90) NS 106 (87) 10 (100) NS
TNM Staging
I 33 (31) 10 (47) .5 37 (32) 6 (60) .1
II 25 (24) 5 (24) NS 27 (23) (30) NS
III 10 (9) 1 (5) 11 (9) 0
IV 38 (36) 5 (24) 42 (36) 1 (10)
Data missing 5 0 5 0
Pain
Yes 41 (37) 3 (14) .04* 42 (34) 2 (20) .4
No 70 (63) 18 (86) 80 (66) 8 (80) NS
(Continues)
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OSCC samples
NGF Expression
P-value
TrkA expression
P-
valueHigh n = 111 (84%) Low n = 21 (16%) High n = 122 (92%) Low n = 10 (8%)
Recurrence
Yes 28 (25) 7 (33) .4 31 (25) 4 (40) .4
No 83 (75) 14 (67) NS 91 (75) 6 (60) NS
Survival status
Alive 38 (34) 10 (48) .2 42 (34) 6 (60) .1
Deceased 73 (66) 11 (52) NS 80 (66) 4 (40) NS
Deceased from disease 23 (32) 3 (27) 26 (33) 0
Note: Comparison between two groups by Pearson's chi-square or Fisher's exact test, where appropriate.
Abbreviations: NGF, nerve growth factor; NS, not significant; OSCC, oral squamous cell carcinoma; TrkA, tyrosine kinase A.
*Significant value. 
TA B L E  3   (Continued)
F I G U R E  3   Kaplan-Meier survival analysis for PNI, NGF and TrkA expression in OSCC. Kaplan-Meier survival plots for overall survival 
(OS) (A), disease-specific survival (DSS) (B) and disease-free survival (DFS) (C) in a cohort of 430 patients with OSCC, PNI-positive OSCC 
represented by red line and PNI-negative OSCC represented in green. Kaplan-Meier survival plots showing the relation between NGF 
expression in 132 OSCC samples and OS (D), DSS (E) and DFS (F), high NGF expression represented by red line and low NGF expression 
represented by green line. Kaplan-Meier survival plots for TrkA expression in 132 OSCC for OS (G), DSS (H) and DFS (I), high TrkA expression 
represented by red line and low TrkA expression represented by green line. (p = Log-Rank test)
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of the role that NGF/TrkA may play in OSCC would be necessary for 
the development of therapy modalities targeting the actions NGF/
TrkA, and this may represent a potential route for the treatment of PNI 
and its related symptoms in OSCC in future.
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